Welcome to our dedicated page for Stem SEC filings (Ticker: STEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Stem, Inc. (NYSE: STEM) provides access to the company’s official regulatory disclosures, including current reports on Form 8-K, annual and quarterly reports when available, and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about Stem’s AI-enabled clean energy software and services business, its PowerTrack platform, and its financial and capital structure.
Recent Form 8-K filings describe events such as quarterly earnings releases, where Stem reports revenue, gross profit, non-GAAP metrics, and recurring revenue indicators like ARR and CARR. Other 8-Ks outline material financing transactions, including the exchange of portions of its 0.50% and 4.25% convertible senior notes for new Senior Secured PIK Toggle Notes and warrants, as well as the implementation of a 1-for-20 reverse stock split of its common stock to address NYSE listing requirements.
Filings also cover corporate governance and leadership changes, such as appointments of executive officers, board appointments, and amendments to the company’s bylaws, including a reduction in the quorum requirement for shareholder meetings. Legal developments, like the dismissal with prejudice of a putative securities class action against Stem and certain former officers and directors, are likewise reported through Form 8-K.
On Stock Titan, these SEC filings are presented with AI-powered tools that help readers interpret complex documents. Users can quickly locate key sections in earnings releases, financing agreements, warrant terms, and governance amendments, and can review how these disclosures relate to Stem’s software-centric strategy and clean energy operations. This page is intended as a centralized view of STEM’s regulatory history, including financial reporting, capital markets activity, and governance updates.
Rule 144 notice filed for a proposed sale of restricted shares. The holder plans to sell 2,076 shares of common stock through Fidelity Brokerage Services LLC on or about November 10, 2025 on the NYSE.
The shares were acquired on November 7, 2025 via restricted stock vesting as compensation. The filing lists an aggregate market value of 37,942.22 for the shares to be sold. Shares outstanding were 8,390,208; this is a baseline figure, not the amount being offered.
Stem, Inc. (STEM)3379 shares of common stock. The proposed sale is through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 11/10/2025 and an aggregate market value of 61756.63.
The shares were acquired on 11/07/2025 via restricted stock vesting from the issuer as compensation. Shares outstanding were 8,390,208.
Stem (STEM) filed a Form 144 notice for a proposed sale of 5,416 common shares on the NYSE. The filing lists an aggregate market value of $98,986.07, with 8,390,208 shares outstanding. The approximate sale date is 11/10/2025, and the broker is Fidelity Brokerage Services LLC.
The shares were acquired on 11/07/2025 through restricted stock vesting from the issuer as compensation. The notice includes the standard representation that the seller does not know of any material adverse information that has not been publicly disclosed.
Stem, Inc. (STEM)Total revenue was
Year-to-date, net income of
Stem, Inc. (STEM) furnished its Third Quarter 2025 results via an 8‑K. On October 29, 2025, the company announced financial results for the quarter ended September 30, 2025 and made its press release available as Exhibit 99.
The materials, including slides, are posted on the Stem Investor Relations website. Consistent with General Instruction B.2., the information is furnished under Items 2.02 and 7.01 and is not deemed filed under Section 18 of the Exchange Act, nor incorporated by reference into Securities Act filings except as expressly stated.
Stem, Inc. amended its bylaws to lower the quorum required to conduct business at stockholder meetings from a majority of the voting power to one-third of the voting power, effective upon Board approval on October 15, 2025. The company cited difficulty achieving a quorum given its large and dispersed stockholder base. This change is intended to reduce the risk of meeting adjournments and the associated added costs for meeting hosting and proxy solicitation, as well as potential operational disruptions and management distractions. The full text of the amendment is filed as Exhibit 3.1.
Brian Musfeldt, Chief Financial Officer of STEM, Inc. (STEM), amended a Form 4 to report equity awards granted on 07/17/2025. The amendment discloses 2,500 RSUs that vest 100% on 08/07/2027, 6,750 PSUs that vest upon meeting a volume-weighted average price target over any consecutive 60 trading-day period, and 1,250 stock options with an exercise price of $9.27 that expire on 07/17/2035 and vest 100% on 08/07/2027. The amended filing corrects omissions and an earlier miscount: the original Form 4 omitted the RSUs and options and reported 5,500 PSUs instead of 6,750 PSUs. All reported awards are listed as direct holdings.
STEM, Inc. filing a Form 144 reports a proposed sale of 134 shares of common stock, with an aggregate market value of $2,670.49, to be sold on or about 10/02/2025 on the NYSE. The shares were acquired by the seller on 09/26/2025 through restricted stock vesting and were received as compensation. The filing lists 8,359,047 shares outstanding for the class. The filer reports no sales of the issuer's securities by the seller in the past three months and includes the standard signer representation that they are not aware of undisclosed material adverse information about the issuer.
Stem, Inc. registers for resale up to 439,919 warrants and up to 439,919 common shares issuable upon exercise of those warrants, issued June 30, 2025, as part of exchanges of its 2028 and 2030 convertible notes. Each warrant is exercisable for one share at $30.00 per share and expires at close of business on December 1, 2030. Stem's common stock trades on the NYSE under STEM; the last reported sale price on September 8, 2025 was $13.50. The prospectus warns of potential dilution, limited warrant liquidity, and directs readers to incorporated SEC filings for risks and financial details.
Stem, Inc. furnished a CEO letter to shareholders from Chief Executive Officer Arun Narayanan. The letter, dated September 9, 2025, was provided as an exhibit to this report to update shareholders outside of the company’s regular periodic filings. The company clarified that this communication is being furnished rather than filed, which means it is not subject to certain liability provisions of the securities laws and will only be incorporated into other filings if specifically referenced.